Assessing for disease: recurrent mycosis fungoides or cutaneous granulomatous drug eruption after mogamulizumab therapy
Crossref DOI link: https://doi.org/10.1007/s12308-020-00411-x
Published Online: 2020-08-12
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Martig, Daniel S.
Bridges, Alina G.
Macon, William R. http://orcid.org/0000-0003-4188-823X
Text and Data Mining valid from 2020-08-12
Version of Record valid from 2020-08-12
Article History
Received: 27 July 2020
Accepted: 5 August 2020
First Online: 12 August 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.